Tezspire is a first-in-class human monoclonal antibody that works by blocking thymic stromal lymphopoietin, an epithelial cytokine involved in the initiation and persistence of airway inflammation.
Recent updates on severe asthma include real-world data on triggers, efficacy of benralizumab and dupilumab, and the approval of Tezspire as add-on maintenance treatment.
Patients who have asthma or who have children who are at risk of developing asthma may wonder what they can do to prevent or control the condition. Does nutrition play a role in helping or worsening asthma, and what can you tell your patients?
The 6-minute pegboard and ring test can be used as a valid and reliable test to evaluate functional arm exercise capacity in patients with well-controlled asthma.
Adolescent boys with a higher BMI, adenotonsillar hypertrophy, and sleep-disordered breathing have an increased risk for moderate to severe obstructive sleep apnea.
The novel ORACLE scale (Oxford Asthma Attack Risk Scale) demonstrated potential to predict — and subsequently prevent — asthma attacks using biomarkers of type 2 airway inflammation.
The primary treatment goals of ABPA include controlling symptoms of asthma or cystic fibrosis, preventing and/or treating pulmonary exacerbation, decreasing pulmonary inflammation, and reducing the progression of pulmonary disease.
